In the Ozempic trials for type 2 diabetes, approximately one in twelve participants reported diarrhoea
Start by washing your hands, and end by throwing away the used items the right way
Previous studies with GLP-1 receptor agonists such as liraglutide have shown cognitive improvements in both animals and humans, and now Tirzepatide may go a step further, offering dual incretin signaling that more comprehensively regulates neuronal metabolism and survival
Additionally, wipe the rubber stopper on your medication vial with an alcohol swab before drawing your dose to maintain cleanliness
Tirzepatide is a synthetic dual incretin receptor agonist (molecular mass 4.8 kDa, water-soluble) that has recently emerged as a novel therapeutic strategy for metabolic disorders by targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors (GLP-1R), leading to marked improvements in glycemic control and body weight in clinical trials for T2DM [4] (Table 1, Figure 1)